Auragens Achieves AABB Accreditation, Marking Major Milestone in Regenerative Medicine Quality and Patient Safety
International regenerative medicine leader earns accreditation from one of the world's most respected organizations in cellular therapy, reinforcing its commitment to quality, traceability, and clinical excellence.
Auragens, a leading regenerative medicine and research institute, today announced that it has achieved accreditation from the Association for the Advancement of Blood & Biotherapies (AABB), a globally recognized organization known for establishing rigorous standards in cellular therapy, biologics, transfusion medicine, and related healthcare services.
The accreditation represents a significant achievement for Auragens and reflects the organization's commitment to maintaining comprehensive quality systems, operational excellence, patient safety, and traceability throughout the regenerative medicine process.
For patients, physicians, and industry stakeholders, the accreditation serves as independent validation that Auragens has implemented and maintains robust systems governing the handling, processing, storage, documentation, and administration of cellular therapy products.
